EU regulator reviews reports of rare nerve disorder after AstraZeneca shot
Europe’s medicines regulator reports a rare nerve-degenerating disorder in people who have received AstraZeneca’s COVID-19 vaccine.
Europe’s medicines regulator reports a rare nerve-degenerating disorder in people who have received AstraZeneca’s COVID-19 vaccine.